Part of the USC/CHLA Cell Therapy Program Seminar Series
 

Speaker: 

Marc Ferrer, Ph.D.
Director, 3-D Tissue Bioprinting Laboratory

Division of Preclinical Innovation
Early Translation Branch
National Center for Advancing Translational Sciences
 

Learn more about : 

• NCATS advances translational sciences through collaborative research.
• NCATS builds translational platforms and technologies to address multiple diseases at a time.
• NCATS uses engineered tissues as a technology platform for disease modeling and drug screening
   

Register today: 

https://usc.zoom.us/webinar/register/8516287837215/WN_wr_DaMgdTQODknw-hWhSYQ